Objective: To present our experience in the first 100 live liver-donors done at King Hussein Medical Center with emphasis on donor postoperative complications and possible risk factors predisposing to complications.
Introduction
Liver transplantation has established its role as the definitive therapy of end-stage liver disease (ESLD).Due to shortage of cadaveric organ donation, the use of living-donor liver transplantation (LDLT) started in the 1989 in pediatric patients followed shortly by its application to adult population (1) . The ethical dilemma of exposing healthy volunteer to major surgery remained an obstacle (2-3) and has led to evolution of the concept of "group risk-benefit ratio". This has been emphasized in Vancouver Forum on the Care of the Live Organ Donor (4) which states that "Live liver donation should only be performed if the risk to the donor is justified by the expectation of an acceptable outcome in the recipient". Thus donor safety is the crux in living liver-donor transplantation programs. In a search for perfection, investigators are trying to identify potentially modifiable risk factors associated with complications in these volunteers rather than patients. With the scarcity of deceased donor liver transplantation (DDLT) clinical, operative and perioperative data of theses donors were prospectively collected for analysis. All postoperative complications were registered. The most severe complication in a particular donor was graded using the Clavien-Dindo Classification of Surgical Complications (5) (6) to allow statistical analysis and comparison of our results with data published in the literature. Follow up ranged from 2 months and up to 6 years after donation with an average of 1 year. Recipient death was the most common cause of dropping out follow up. Statistical analysis was done using IBM Statistical Package for the Social Sciences software (SPSS Statistics 21). Factors including age, gender, BMI, type of hepatectomy, estimated future liver remnant (FLR), preoperative liver enzymes and total bilirubin were analyzed trying to identify potential risk factors of complications. Chisquare and one-way analysis of variance (ANOVA) tests were utilized when appropriate. A p-value less than 0.05 was considered statistically significant. Approval by our institution ethical committee was obtained for publication.
Results
Our first 100 donors were included over the study period of 11 years. 71 donors were males and the mean age was 30.71±7.17 years with a range of 19-52 years. The BMI ranged from 19.1-30.4 with a mean of 24.50± 2.56. Forty-four were first-degree relatives of the recipients with the remaining being second or third degree relatives or wife of recipients as shown in Table  I . Table I An overall complication rate of 36% has been reported. Most of these were minor grade I and II (26%) complications. The mortality rate was zero (Table II) The initial 42 cases were done with the Turkish team from the start of our program till July 2009. Thereafter, 58 cases were done by us (Table III) . Comparing the two eras, there was no statistically significant difference in incidence or severity of complications (pvalue 0.895). By using ANOVA, higher mean age and BMI were associated with occurrence of complications. Donors who developed complications had a significantly higher mean age than those who did not. On subset analysis this was validated for major type III & IV complications but not for minor Type I and II complications (Figure1). A higher BMI was found to be a risk factor for all types of complications (Figure2). There was no statistically significant effect of gender, type of hepatectomy performed and estimated FLR on occurrence of complications. Since the FLR is rarely a problem in donors undergoing left hepatectomy and left lateral sectorectomy, we have re-analyzed data of donors who underwent right hepatectomy with or without inclusion of MHV. We also analyzed the impact of MHV harvesting on development of complications. Neither FLR in right hepatectomy nor inclusion of the MHV was found to significantly associated with occurrence of complications (Table III-VI). 
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None of preoperative biochemical liver markers (AST, ALT, ALP & total bilirubin) was predictive of complication (Table VII) . 
Discussion
The shortage of liver donation coupled with a high mortality rate of recipient on transplantation waiting list has resulted in temptations to extend donor criteria for liver donation (e.g. age>55, BMI>30, up to 30% hepatosteatosis, FLR<30%).
Such temptations should be balanced by perfect donor outcomes with minimal morbidity and no mortality of these volunteers. Donor morbidity rate worldwide is estimated at 25-40% with around 0.2-0.5 % mortality. (8) Although most complications are minor, they result in prolongation of hospital stay, exaggeration of cost and poor overall donor satisfaction.
(9-10) Our outcomes are comparable to published data with 36% overall morbidity rate and 10% major complication rates. 7 complications were completely preventable (6 caval clamp failures and one respiratory failure attributed to anesthesia). Standardized and transparent reporting of adverse donor outcomes is of paramount importance and continuous clinical auditing is warranted. Researchers have tried to identify modifiable risk factors of complications in donor hepatectomy but till now no such factor exist since donors are typically healthy individuals with no comorbidities. Older age, higher BMI, both male and female genders, surgical experience and smaller FLR have all been suggested as risk factors. In this study, we have found that older age is associated with increased risk of development of major grade III and IV complications. This may be partly related to a reduced regenerative capacity of the liver as suggested by many studies. A higher mean BMI was found in patients who develop all grades of complication. Obesity is well known risk factor for postoperative pulmonary, wound and thromboembolic complications as well as incisional hernia. In donor hepatectomy this is even exaggerated by the use of big J-shaped subcostal incision and prolonged operative time. It is also a marker of hepatosteatosis which impairs the regenerative capacity of the liver and may lead to prolonged postoperative cholestasis in the donor and delayed primary function in the recipients. Obese potential donors should be avoided or else should be offered a dietician consult followed by reevaluation after successful weight loss. In these donors liver biopsy for evaluation of hepatosteatosis is mandatory. The future liver remnant (equals estimated total liver volume-estimated graft volume/ total liver volume) is a major determinant of outcome after any hepatectomy. A FLR>25% is considered the lowest safety margin for resection of normal liver. This may be applicable for patients with malignant liver tumors since the benefit outweighs the risk and should not be generalized to donor hepatectomy where the donor has no direct benefit from the operation (16) (17) (18) .The lack of correlation between FLR and out come in our study is mostly due to strict selection of donors. Potential donors with an estimated FLR <30% as measured by CT scan are rejected. 6 donors in our study had FLR <30% after hepatectomy (i.e. estimated total liver volume -weight of graft). 3 of these had minor complications and none developed major type III & IV complications. Compared to the whole cohort this was insignificant (pvalue as calculated by Chi-square test 0.674). Neither the type of the graft nor inclusion of MHV in right hepatectomy was found to adversely affect donor outcome. This finding however should be cautiously taken since only 12 right hepatectomies with MHV, 11 left hepatectomies and 3 left lateral sectorectomies were included in this study. This mandates future studies including more donors who undergo left donor hepatectomies. Although some studies have found a positive correlation between complications and preoperative alkaline phosphate test ALP and total bilirubin level (22) we have not found any correlation between routinely measured liver enzymes or total bilirubin and occurrence of complications. Actually, we do not accept donors with abnormal liver biochemical tests and our finding is in concordance with most studies published on this issue.
(23-24)
Conclusion
Strict donor selection and meticulous surgical procedure remain the only modifiable factors to avoid complications after donor hepatectomy (25) . Presence of more than one risk factor (older age, higher BMI, hepatosteatosis, expected FLR<30%) in a potential donor may be considered as relative contraindication to liver donation. Continuous transparent clinical audit of outcome is mandatory to identify potentially preventable adverse outcomes.
